Medication-Related Osteonecrosis of the Jaws (MRONJ). Case Report And Update.
Jorge A. Cano-DuránDDS. Oral Medicine Postgraduate . School of Dentistry of the Complutense University of MadridDaniel Ortega ConcepciónDDS. Oral Medicine Postgraduate. School of Dentistry of the Complutense University of MadridJuan‐Francisco Peña‐CardellesDepartment of Medicine and Orofacial surgery. School of Dentistry of the Complutense University of MadridJosé González‐SerranoDDS. Oral Medicine Postgraduate. Postgraduate student inMariano García-RiartDDS. Oral Medicine Postgraduate. Postgraduate student in Master degree program of Oral Surgery and Implantology. School of Dentistry of the Complutense University of MadridVíctor Manuel Paredes-RodríguezDepartment of Medicine and Orofacial surgery. School of Dentistry of the Complutense University of MadridJuan López-QuilesDDS. MD. phD. Specialist in Oral and Maxillofacial Surgery . Professor contracted doctor of the Department of Medicine and Orofacial surgery . School of Dentistry of the Complutense University of Madrid
2017en
ABI
Annotatsiya
Background.Antiresorptive drugs are used to prevent bone resorption derived from different diseases.One of the most frequent complications of these drugs is the osteonecrosis of the jaws (ONJ).Case report.We report the case of an 82-year-old male presenting multiple ONJ lesions in the maxilla associated with the trauma of a removable partial denture and the bisphosphonates intake.Discussion.The main controversy of ONJ lesions is the treatment that should be performed.Although it has been seen that there is no a totally effective therapy for ONJ, currently there are some promising and noninvasive techniques that seem to be effective, improving the quality of life of the patient.
Hali tarjima qilinmagan
Identifikatorlar
Iqtiboslar va manbalar
0 ta iqtibos22 ta foydalanilgan manba